Manufacture of Immunoglobulin Products for Patients With Primary Antibody Deficiencies €“ the Effect of Processing Conditions on Product Safety and Efficacy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2014.00665
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Clinical Recommendations for Oral Management of Patients With Primary Antibody Deficiencies

Expert Review of Clinical Immunology
AllergyImmunology
2016English

Correction: Consensus on Diagnosis and Management of Primary Antibody Deficiencies

BMJ
1994English

The Management of Patients With Osteoarthritis by a Primary Care Physician: Focus on Efficacy and Safety

Medical Council
2018English

Adequate Patient’s Outcome Achieved With Short Immunoglobulin Replacement Intervals in Severe Antibody Deficiencies

Journal of Clinical Immunology
AllergyImmunology
2014English

Efficacy of the Mica Antibody for Transplant Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Product Safety Activities for Preventing Human Errors Related With Consumer Products

Journal of the Ergonomics Society of Korea
2011English

Prace Poglądowe Folate Supplementation in Patients With Psoriasis Treated With Methotrexate – Effect on Safety and Efficacy

Przeglad Dermatologiczny
Dermatology
2014English

Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis

Arthritis Research & Therapy
2020English

Efficacy and Safety of Octanorm (Cutaquig®) in Adults With Primary Immunodeficiencies With Predominant Antibody Deficiency: A Prospective, Open-Label Study

Immunotherapy
OncologyAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy